Letters to the Editor

Real-world safety and efficacy of rADAMTS13 prophylaxis in congenital thrombotic thrombocytopenic purpura: experience from Polish patients previously treated with fresh frozen plasma

Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland; Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine, Warsaw
Department of Hematology and Internal Medicine, University Hospital in Cracow, Cracow
Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw
Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw
Department of Pediatric Oncology, Hematology and Transplantology Poznan University of Medical Sciences Karol Jonscher Clinical Hospital Institute of Pediatrics
Department of Oncology, Pediatric Hematology, Trasplantology and Pediatrics, Medical University of Warsaw
Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice
Department of Pediatrics, Oncology and Hematology, Medical University of Lodz
Oncology and Hematology Department, University Children’s Hospital of Cracow
Department of Haematology and Transplantology, Faculty of Medicine, Medical University of Gdansk, Gdansk
General Hematology Department, Copernicus Memorial Hospital, Lodz
Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine, Warsaw
Department of Pediatrics, Oncology and Hematology, Medical University of Lodz
Haematologica Early view Oct 2, 2025 https://doi.org/10.3324/haematol.2025.288561